We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current HJLI market cap is 98.32M. The company's latest EPS is USD -2.4827 and P/E is -4.18.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.15M | -6.46M | -6.8M | -6.81M | -5.35M |
| Net Income | -6.1M | -6.18M | -6.39M | -6.47M | -5M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 31k | 0 | 0 | 0 | 0 |
| Operating Income | -7.09M | -9.14M | -16.89M | -24.93M | -25.24M |
| Net Income | -7.63M | -9.74M | -16.53M | -24.67M | -23.52M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 45.46M | 41.66M | 36.61M | 32.09M | 28.09M |
| Total Liabilities | 2.79M | 2.93M | 2.48M | 3.27M | 3.18M |
| Total Equity | 42.67M | 38.73M | 34.13M | 28.81M | 24.92M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 3.43M | 10.54M | 57.7M | 41.66M | 48.64M |
| Total Liabilities | 2.44M | 3.44M | 3.3M | 2.93M | 2.44M |
| Total Equity | 990k | 7.1M | 54.4M | 38.73M | 46.2M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -11.76M | -15.62M | -5.11M | -9.67M | -13.89M |
| Investing | -40.07M | -34.55M | 2.83M | 9.83M | 14.28M |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.9M | -7.68M | -11.85M | -15.62M | -18.86M |
| Investing | -364k | -180k | -368k | -34.55M | -7.87M |
| Financing | 5.64M | 15.08M | 57.61M | N/A | 25.79M |
| Market Cap | 98.32M |
| Price to Earnings Ratio | -4.18 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 27.16 |
| Price to Book Ratio | 2.13 |
| Dividend Yield | - |
| Shares Outstanding | 9.47M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.7 (6.54%) |
| Company Name | Hancock Jaffe Laboratories Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.envveno.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
